Nyra Medical announced that it began the first-in-human clinical study evaluating its novel cardiac leaflet enhancer (CARLEN) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results